Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.53 |
| ▸ | MAOB known ✓ | P27338 | 3/20 | 0.48 |
| ▸ | MAOA known ✓ | P21397 | 2/20 | 0.48 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.43 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.43 |
| ▸ | DRD4 known ✓ | P21917 | 1/20 | 0.43 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.43 |
| ▸ | RET known ✓ | P07949 | 1/20 | 0.40 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.40 |
| ▸ | MAPK14 known ✓ | Q16539 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.46 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.46 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.46 |
| ▸ | CD44 | P16070 | 1/20 | 0.46 |
| ▸ | DRD5 | P21918 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28647349 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL330529 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL21176564 | 0.96 | TSHR (0.67) | TSHRHTR2CCYP2A6MAOBMAOA | |
| Bromide SCHEMBL28479076 | 0.92 | TSHR (0.62) | TSHRHTR2CCYP2A6MAOBMAOA | |
| Iodide SCHEMBL29238184 | 0.92 | TSHR (0.62) | TSHRHTR2CCYP2A6MAOBMAOA | |
| SCHEMBL29351986 | 0.92 | — | — | |
| SCHEMBL4465325 | 0.92 | TSHR (0.71) | TSHRHTR2CCYP2A6MAOBMAOA | |
| SCHEMBL34906 | 0.92 | — | — | |
| SCHEMBL33555 | 0.92 | — | — | |
| Bromide SCHEMBL917076 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120091702-A | Perovskite solar cell based on co-self-assembled molecule induced interface in-situ polymerization and preparation method thereof | 南方科技大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119907614-A | Perovskite precursor solution, perovskite thin film, preparation method of perovskite thin film, photoelectric device and electricity utilization device | 天合光能股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-222424622-U | Perovskite solar cell and electricity utilization device | 天合光能股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118338747-A | Solar cell and preparation method thereof | 天合光能股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118302015-A | Perovskite layer preparation method, perovskite battery, perovskite layer preparation method and electricity utilization device | 天合光能股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-12024648-B2 | Graphene anti-corrosion coating | TORAY INDUSTRIES, INC. (JP) | 2024-07-02 | — | — | US | claimed |
| CN-117700964-A | Environment-friendly degradable composite material | 昕亮科技（深圳）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117417628-A | Heat-resistant degradable plastic and preparation method thereof | 昕亮科技（深圳）有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-113039251-B | Graphene anticorrosive paint | 东丽先端材料研究开发（中国）有限公司 | 2022-09-09 | — | — | CN | claimed |
| US-20210395536-A1 | GRAPHENE ANTI-CORROSION COATING | TORAY INDUSTRIES, INC. (JP) | 2021-12-23 | — | — | US | claimed |
| EP-3889224-A1 | GRAPHENE ANTI-CORROSION COATING | Toray Industries, Inc. (JP) | 2021-10-06 | — | — | EP | claimed |
| CN-113039251-A | Graphene anticorrosive paint | 东丽先端材料研究开发（中国）有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-107400070-A | Biguanides probe and preparation method thereof | 清华大学 | 2017-11-28 | — | — | CN | claimed |
| CN-120091702-A | Perovskite solar cell based on co-self-assembled molecule induced interface in-situ polymerization and preparation method thereof | 南方科技大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-119907614-A | Perovskite precursor solution, perovskite thin film, preparation method of perovskite thin film, photoelectric device and electricity utilization device | 天合光能股份有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119789742-A | Perovskite solar cell based on perovskite thin film crystallization control and preparation method | 西安交通大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-107400070-A | Biguanides probe and preparation method thereof | 清华大学 | 2017-11-28 | — | — | CN | disclosed |
| US-20040006081-A1 | Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity | ASTRAZENECA AB (SE) | 2004-01-08 | — | — | US | disclosed |
| EP-1289957-A1 | PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001087839-A1 | PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2001-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006081-A1 | Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity | CCR5, CCR2, CCR1 | HTR2C 799/4885MAOB 2844/4885MAOA 3065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.